Scientia Agricultura Sinica ›› 2018, Vol. 51 ›› Issue (17): 3405-3414.doi: 10.3864/j.issn.0578-1752.2018.17.015

• ANIMAL SCIENCE·VETERINARY SCIENCERE·SOURCE INSECT • Previous Articles     Next Articles

Domestication of Suspended MDCK Cells and Cultivation of H5 Subtype Avian Influenza Virus

CHEN Hong1, YANG Liu1, SONG HaiYan1, SHI Ying1, MENG LingWei1, FU ChunJie1, Zhang Dan1, ZHAO HaiYuan1, LI JinXiang2, JIANG XiaoMei3, ZHANG TianShu3   

  1. 1Jilin Guanjie Biotechnology co. LTD, Meihekou 135000, Jilin2Chinese Academy of Agricultural Sciences, Beijing 1000813The Xinjiang Uygur Autonomous Region Academy of animal science, Urumqi 830000
  • Received:2018-04-18 Online:2018-09-01 Published:2018-09-01

Abstract: 【Objective】This study provided data support for assessing the effectiveness of cell-derived reassortant influenza virus H5 subtype inactivated vaccines.【Method】 A clearly defined MDCK cells was selected to be domesticated to suspend MDCK cells, and the reassortant avian influenza virus H5N1 Re-6 strain, Re-7 strain and Re-8 strain were proliferated in it. The proliferation differences of different strains in the adherent and suspended MDCK cells were compared. The reassortant avian influenza virus (H5 subtype) trivalent inactivated vaccine were prepared by suspended MDCK cells and by SPF chicken embryo, respectively, which were immuned in commercial chicken and commercial duck. Immune effects were compared between cell source and chicken embryo source by serological methods. 6 050 Hy-line brown laying hens were divided into 3 groups: 2 groups were immunized groups, 3 000 hens in each group, immunized 0.5 ml/head at 28 days of age and 80 days of age; 1 non-immunized control group, 50 hens were reared under the same conditions. The serums were collected from the layers at 49 days, 110 days, and 210 days (ie, 21 days, 82 days, and 6 months after the first immunization) to determine the reassortant avian influenza virus H5 subtype Re-6 strain, Re-7 strain and Re-8 strain, The HI antibody titer was monitored. 220 Changbai flying ducks were divided into 3 groups: 2 groups were immunized groups, 100 ducks in each group, immunized 0.5 ml/head at 10 days of age, immunized 1.0 ml/head at 24 days of age; 20 ducks in non-immunized control group, under the same conditions. The serums were collected at 24, 38, and 52 days (ie, 14 days, 28 days, and 42 days after the first immunization) to determine the reassortant avian influenza virus H5 subtype Re-6 strain, Re-7 strain and Re-8 strain, and the HI antibody titer was monitored. 【Result】A MDCK cell that could be grown in serum-free medium was obtained. Culture data, cell status in shake flasks and 5L bioreactors showed that the cell line was suitable for scale-up production. The cell density was cultured from 1.5×106 cells/ml to 1.0×107 cells/ml in 48-hours. Under the good condition, the cells had a high activity rate, and were individually suspended in the medium. The H5N1 reassortant avian influenza virus were produced in the suspension MDCK cells, Re-6 strain: HA titer 1﹕512, TCID50 107.67/mL, EID50 107.83/0.1mL; Re-7 strain: HA titer 1﹕512, TCID50 107.33/ml, EID50 107.17/0.1mL; Re-8 strain: HA titer 1﹕1024, TCID50 108.5/mL, EID50 108.38/0.1mL. The results was similar to that of the adherent MDCK cells. Cell-derived trivalent inactivated vaccine was used to immunize y-line brown laying hens after 21 days of the first immunization, and the average HI antibody titer of the avian influenza virus H5 subtype strain Re-6, Re-7 and Re-8 in serum was 1﹕446, 1﹕111, and 1﹕416. The average HI antibody titer of the three groups was 1﹕588, 1﹕362, and 1﹕776 at 30 days after secondary immunization, and they were 1﹕239, 1﹕128, and 1﹕223 at 6 months, maintaining high antibody levels. Changbai flying duck were immured, after 14 days of the first immunization, the average HI antibody titer of the avian influenza virus H5 subtype strain Re-6, Re-7 and Re-8 in serum was 1﹕30, 1﹕17, and 1﹕64. The average HI antibody titer of the three groups was 1﹕194, 1﹕91, and 1﹕137 at 28 days, and they were 1﹕416, 1﹕128, and 1﹕239 at 42 days. The experimental results of the above two groups were equivalent to those derived from chicken embryo.【Conclusion】A domesticated MDCK cell line that could be grown in serum-free medium, and were used as host cells to produce reassortant avian influenza virus. Its ability to proliferate reassortant avian influenza virus H5N1strain Re-6, Re-7 and Re-8 was strong. Viruses that were prepared as inactivated vaccines to immunize y-line brown laying hens and Changbai flying duck produced higher levels of antibodies. This study provided technical support for large-scale industrial production of the avian influenza vaccine.

Key words: MDCK cells, reassortant avian influenza virus, suspension culture, immune effect

[1]    刘金华, 甘孟侯.中国禽病学. 北京: 中国农业出版社, 2016: 108-114.
LIU J H, GAN M H. China Poultry Diseases. Beijing: China Agriculture Press, 2016: 108-114. (in Chinese)
[2]    UYEKI T M. Global epidemiology of human infections with highly pathogenic Avian Influenza A(H5N1) Viruses. Respirology, 2008, 13(Suppl 1): 2-9.
[3]    何长生, 朱良强, 郑举, 占松鹤, 江定丰, 刘华, 王非, 王军, 曹晋蓉, 洪功飞, 袁松 . 对重组禽流感病毒灭活疫苗(H5N1亚型, Re-1株)在家禽免疫效果方面的调研. 中国兽药杂志, 2008, 42(7): 30-32.
HE C S, ZHU L Q, ZHENG J, ZHAN S H, JIANG D F, LIU H, WANG F, WANG J, CAO J R, HONG G F, YUAN S. Investigation of the immunity efficacy of recombinant inactivation vaccine(subtype H5N1, Re-1 strain) for poultry. Chinese Journal of Veterinary Drug, 2008, 42(7): 30-32. (in Chinese)
[4]    张良艳, 姚志东, 邢丽, 顾超逸, 刘坤, 王希良. MDCK细胞的悬浮驯化及初步应用. 生物技术通讯, 2013, 24(3): 382-384.
ZHANG L Y, YAO Z D, XING L, GU C Y, LIU K, WANG X L. Conversion of MDCK cell line to suspension culture and its application for influenza virus production. Biological Technology Communication, 2013, 24(3): 382-384. (in Chinese)
[5]    FENG S Z, JIAO P R, QI W B, FAN H Y, LIAO M. Development and strategies of cell-culture technology for influenza vaccine. Applied Microbiology and Biotechnology, 2011, 89: 893-902.
[6]    YOUIL R, SU Q, TONER T J, SZYMKOWIAK C, KWAN W S, RUBIN B, PETRUKHIN L, KISELEVA I, SHAW A R, DISTEFANO D. Comparative study of influenza virus replication in vero and MDCK cell lines. Journal of Virological Methods, 2004, 120(1): 23-31.
[7]    DOROSHENKO A, HALPERIN S A. Trivalent MDCK cell culture- derived influenza vaccine Optaflu®(Novartis Vaccines). Expert Review of Vaccines, 2014, 8(6): 679-688.
[8]    HU AY, TSENG Y F, WENG T C, LIAO C C, WU J, CHOU A H, CHAO H J, GU A, CHEN J, LIN S C, HSIAO C H, WU S C, CHONG P. Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium. PLoS One, . 2011, 6(1): e14578
[9]    杨思思, 汪一名, 李媛媛. MDCK细胞悬浮培养技术在流感疫苗中的应用. 科技创新与生产力, 2017(10): 44-48.
YANG S S, WANG Y M, LI Y Y. Application of MCDK cell suspension culture in influenza vaccine. Technological Innovation and Productivity, 2017(10): 44-48. (in Chinese)
[10]   冯磊, 吴培培, 褚轩, 王伟峰, 陈丽, 侯继波. MDCK单细胞悬浮生长的驯化筛选及其在AIV增殖上的初步应用. 浙江农业学报, 2015, 27(6): 913-920.
FENG L, WU P P, CHU X, WANG W F, CHEN L, HOU J B. Adaptation and screening of MDCK cells in sing-cell suspension growth mode for AIV replication. Zhejiang Journal of Agricultural Sciences, 2015, 27(6): 913-920. (in Chinese)
[11]   万玉林, 陶世宇, 武发菊, 柴立丽, 安芳兰, 杨进才, 刘学荣. 犬肾细胞MDCK研究进展. 安徽农业科学, 2017, 45(23): 96-98.
WAN Y L, TAO S Y, WU F J, CHAI L L, AN F L, YANG J C, LIU X R. Advances in the study of MDCK. Anhui Agricultural Science, 2017, 45(23): 96-98. (in Chinese)
[12]   MADIN S H, JR D N. Established kidney cell lines of normal adult bovine and ovine origin. Proceedings of the Society for Experimental Biology and Medicine, 1958, 98(3): 574-576.
[13]   RINDLER M J , CHUMAN L M , SHAFFER L , JR SAIER M H . Retention of differentiated properties in an established dog kidney epithelial cell line(MDCK). Journal of Cell Biology, 1979, 81: 635-648.
[14]   黄锭, 赵亮. 犬肾细胞MDCK无血清贴壁及单细胞悬浮培养. 生物工程学报, 2011, 27(4): 645-652.
HUANG D, ZHAO L. Adherent and single-cell suspension culture of Madin-Darby canine kidney cells in serum-free medium. Journal of Bioengineering, 2011, 27(4): 645-652. (in Chinese)
[15]   王丽萍, 李晓燕, 王敏, 韩天龙. 新城疫、禽流感(H9亚型)二联灭活苗不同免疫剂量对海兰褐壳蛋鸡生产性能的影响. 黑龙江畜牧兽医, 2017(8): 134-135.
WANG L P, LI X Y, WANG M, HAN T L. Effects of different immunological doses of Newcastle disease and avian influenza(H9 subtype) inactivated vaccine on the production performance of Hailan brown shell egg chickens. Heilongjiang Animal Science and Veterinary Medicine, 2017(8): 134-135. (in Chinese)
[16]   胡井雷, 刘景利, 杨帆, 徐姗姗, 张从禄, 刘光磊, 田国彬, 孙建 宏. 禽流感病毒H5亚型血凝抑制试验抗原国家参考品的研制. 中国兽药杂志, 2014, 48(3): 27-29.
HU J L, LIU J L, YANG F, XU S S, ZHANG C L, LIU G L, TIAN G B, SUN J H. Preparation of national reference material for avian influenza virus(H5 subtype) hemagglutination inhibition test antigen. Chinese Journal of Veterinary Drug, 2014, 48(3): 27-29. (in Chinese)
[17]   吴培培, 唐应华, 褚轩, 王伟峰, 陈丽, 侯继波, 冯磊 . 适应H9亚型禽流感病毒增殖的MDCK悬浮细胞株的驯化及其生物学特性. 江苏农业学报, 2016, 32(6): 1377-1383.
WU P P, TANG Y H, CHU X, WANG W F, CHEN L , HOU J B, FENG L. Domestication of MDCK suspension cell lines for the H9 subtype of avain influenza virus proliferation and its biological characteristics evaluation. Jiangsu Journal of Agricultural Sciences, 2016, 32(6): 1377-1383. (in Chinese)
[18]   国家药典委员会. 中国人民共和国兽药典•三部. 2015年版. 北京: 中国医药科技出版社, 2015.
Chinese Pharmacopoeia Commission. The People’s Republic of China Volume . 2015 Edition. Beijing: China Medical Science Press, 2015. (in Chinese)
[19]   李晓丽. 鸡常用采血技术及注意事项. 中国畜禽种业, 2017, 13(08): 29.
LI X L. Routine blood collection techniques and precautions for chickens. The Chinese livestock and poultry breeding, 2017, 13(08): 29. (in Chinese)
[20]   代为俊, 刘旭平, 周燕. 基于MDCK悬浮细胞生产禽流感疫苗的放大工艺开发. 中国兽药杂志, 2017, 8(8): 46-51.
DAI W J, LIU X P, ZHOU Y. Development of scale up for the production of influenza vaccine based on MDCK suspension cells. Chinese Journal of Veterinary Drug, 2017, 8(8): 46-51. (in Chinese)
[21]   刘鹏, 李佳林, 马超, 赵祖波 . H1N1流感病毒在微载体培养MDCK细胞上增殖的研究. 微生物学免疫学进展, 2013, 41(1): 12-15.
LIU P, LI J L, MA C, ZHAO Z B. Research on multiplication of the H1N1 subtype influenza virus in large-scale micro-carrier-based MDCK cell culture system. Progress in Microbiology and Immunology, 2013, 41(1): 12-15. (in Chinese)
[22]   彭英波. 山区家禽禽流感免疫抗体监测与分析. 中国畜牧兽医文摘, 2014, 30(5): 129-131.
PENG Y B. Monitoring and analysis of avian influenza immunological antibody in mountain poultry. Chinese Abstracts of Animal Husbandry and Veterinary Medicine, 2014, 30(5): 129-131. (in Chinese)
[23]   沈欣悦, 程旭, 刘梅, 尤素兰, 刘加圣, 戴亚斌 . 重组禽流感病毒灭活疫苗(H5N1亚型)对鸭和鹅的免疫效果观察. 中国动物传染病学报, 2013, 21(4): 40-45.
SHEN X Y, CHENG X, LIU M, YOU S L, LIU J S, DAI Y B. Immune effect of reasortant avian influenza virus inactivated vaccine(H5N1 subtype) on ducks and geese. Chinese Journal of Animal Infectious Diseases, 2013, 21(4): 40-45. (in Chinese)
[24]   金大春, 肖剑, 王跃川, 潘杭君, 董信田. H5亚型禽流感疫苗对蛋鸭免疫效果的研究. 中国畜牧兽医, 2008, 35(4): 96-98.
JIN D C, XIAO J, WANG Y C, PAN H, DONG X T. Study on immune effect of H5 subtype avian influenza vaccine on egg duck. China Animal Husbandry and Veterinary Medicine, 2008, 35(4): 96-98. (in Chinese)
[25]   原丽丽, 李永刚, 郑书涛, 葛春旭. 规模化蛋鸡场H5亚型禽流感疫苗免疫程序与抗体水平分析. 中国家禽, 2007, 24: 2-4.
YUAN L L, LI Y G, ZHENG S T, GE C X. Immunological program and antibody level analysis of H5 subtype avian influenza vaccine in large scale egg chicken farm. China Poultry, 2007, 24: 2-4. (in Chinese)
[26]   李慧娇. 中国禽用疫苗的研发与生产现状. 家禽科学, 2007, 10: 3-4.
LI H J. Research and production of avian vaccine in China. Poultry Science, 2007, 10: 3-4. (in Chinese)
[27]   张婷婷. 重组禽流感病毒灭活疫苗生产工艺优化. 中国动物保健, 2016, 5: 32-33.
ZHANG T T. Optimization of production process of reasortant avian virus inactivated vaccine. China Animal Health, 2016, 5: 32-33. (in Chinese)
[28]   杨涛, 刘明, 张云, 刘春国, 王洪峰, 蔡雪辉. 重组H5N3禽流感疫苗株在MDCK细胞中大规模增殖条件研究. 中国预防兽医学报, 2007, 29(3): 199-203.
YANG T, LIU M, ZHANG Y, LIU C G, WANG H F, CAI X H. Multiplication of the recombinant H5N3 influenza vaccine candidate strain in large-scale MDCK cell culture systems. Chinese Journal of Preventive Veterinary Medicine, 2007, 29(3): 199-203. (in Chinese)
[29]   智海东, 王云峰, 陈洪岩. 我国兽用基因工程疫苗研发现状与策略. 动物医学进展, 2011, 6: 174-178.
ZHI H D, WANG Y F, CHEN H Y. Clinical strategies for T cell immune reconstitution. Progress in Veterinary Medicine, 2011, 6: 174-178. (in Chinese)
[30]   陶源, 胡又佳, 朱宝泉. 基于哺乳动物细胞培养的流感疫苗生产. 世界临床药物, 2011, 32(9): 539-542.
TAO Y, HU Y J, ZHU B Q. Progress in production of influenza vaccine by mammalian cells. World Clinical Drugs, 2011, 32(9): 539-542. (in Chinese)
[1] JiaQi WANG,YuHong DONG,JuLing JIANG,JianNing QIAN,WenTao WEI,GuoLiang SONG,JinBo JIAO,XinXin GUAN,GuoBiao JI,YeXin ZHANG. Based on PK15 Cell Line for PCV2 Fully Suspension Culture Process [J]. Scientia Agricultura Sinica, 2021, 54(6): 1280-1287.
[2] LI Li, DU XIN, ZHANG LiNa, YANG Liu, GAO XiaoQing, TANG DongXue, ZHAO HaiYuan, JIANG XiaoMei, ZHANG TianShu, LI JinXiang. Optimization of Cultivation Conditions for Reassortant Avian Influenza Virus H7N9 H7-Re1 Strain [J]. Scientia Agricultura Sinica, 2018, 51(17): 3415-3426.
[3] ZHENG Ming-Xue, GU Shao-Peng, WANG Li-Xia, HAN Ke-Guang, LI Bao-Jun. Effect on E. tenella Invasion into Host Cells in Vitro by Inhibiting Calcium Signal Transduction [J]. Scientia Agricultura Sinica, 2011, 44(15): 3272-3278.
[4] . Enhancement effect of CpG DNA on the somatostatin DNA vaccine in mice [J]. Scientia Agricultura Sinica, 2007, 40(4): 834-841 .
[5] ,,,. Analysis of Synergetic Induction of Hypersensitive Response by Nitric Oxide and Hydrogen Peroxide in Rice Suspension Cultured Cells [J]. Scientia Agricultura Sinica, 2006, 39(01): 61-65 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!